Clinical trials
Recruiting Papillomavirus Infections trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Bovax Biotechnology Co., Ltd. | 3 |
| First Affiliated Hospital of Wenzhou Medical University | 1 |
| Fujian Maternity and Child Health Hospital | 1 |
| National Vaccine and Serum Institute, China | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Papillomavirus Infections | 7 |
| Condylomata Acuminata | 3 |
| Squamous Intraepithelial Lesions | 3 |
| Uterine Cervical Neoplasms | 2 |
| Vaginal Neoplasms | 2 |
| Uterine Cervical Dysplasia | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.